{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:53:59Z","timestamp":1779256439989,"version":"3.51.4"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T00:00:00Z","timestamp":1752883200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Hum Genet"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>DNA repair disorders are a group of conditions characterized by progressive, multisystem phenotypes. Defining new clinical presentations of these disorders is essential for optimizing patient care. ERCC1-XPF is a multifunctional endonuclease involved in nucleotide excision repair (NER) and interstrand crosslink (ICL) repair. We sought to define a novel multisystem phenotype associated with biallelic <jats:italic>ERCC1<\/jats:italic> variants and impaired DNA repair. Through international collaboration, we identified seven individuals from five families carrying biallelic <jats:italic>ERCC1<\/jats:italic> variants, including p.Arg156Trp and p.Ala266Pro, who exhibited a distinct clinical phenotype. All individuals presented with growth restriction, photosensitivity, and kidney and liver dysfunction. Notably, three children required liver transplants. Hepatocellular carcinoma developed in four children, resulting in two deaths, including one following treatment with doxorubicin and cisplatin. Older individuals exhibited additional features, including ataxia, basal cell carcinomas, pancreatic insufficiency, ovarian failure, hypothyroidism, and restrictive lung disease. Functional assays using patient-derived fibroblasts demonstrated significant destabilization of the ERCC1-XPF complex and defects in NER and ICL repair. However, residual NER and ICL repair activity was observed, suggesting a hypomorphic effect of the missense variants, which were present either in the homozygous state or in trans with a predicted loss-of-function allele. We define <jats:italic>ERCC1<\/jats:italic>-hepatorenal syndrome as a severe, multisystem DNA repair disorder associated with high morbidity and mortality, including a significant risk of pediatric hepatocellular carcinoma. We propose management guidelines emphasizing cancer surveillance and caution with chemotherapy to minimize treatment-related toxicity.<\/jats:p>","DOI":"10.1038\/s41431-025-01910-0","type":"journal-article","created":{"date-parts":[[2025,7,19]],"date-time":"2025-07-19T11:46:03Z","timestamp":1752925563000},"page":"1252-1263","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A new multisystem ERCC1-hepatorenal syndrome: insights from a clinical cohort, molecular pathogenesis, and management guidelines"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7611-634X","authenticated-orcid":false,"given":"Susan M.","family":"White","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annelotte P.","family":"Wondergem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isa","family":"Breet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0026-2848","authenticated-orcid":false,"given":"Maren","family":"Dittmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katrina","family":"Bell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9778-4344","authenticated-orcid":false,"given":"Christopher M.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winita","family":"Hardikar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanika","family":"Bhatia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Quinlan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Areetha","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2180-0790","authenticated-orcid":false,"given":"Walter J.","family":"Chazin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Sparkes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0770-5516","authenticated-orcid":false,"given":"Robert J.","family":"Hopkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leticia","family":"Khendek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bonnie R.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naja","family":"Becher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Katrine W.","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9015-4539","authenticated-orcid":false,"given":"Helene","family":"Kvistgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine","family":"Dempsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander G.","family":"Miethke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pernille Ax\u00e9l","family":"Gregersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7442-3167","authenticated-orcid":false,"given":"Eliza","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5796-6541","authenticated-orcid":false,"given":"Martijn S.","family":"Luijsterburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,7,19]]},"reference":[{"key":"1910_CR1","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1056\/NEJMra1703366","volume":"377","author":"G Keijzers","year":"2017","unstructured":"Keijzers G, Bakula D, Scheibye-Knudsen M. Monogenic diseases of DNA repair. New Engl J Med. 2017;377:1868\u201376.","journal-title":"New Engl J Med"},{"key":"1910_CR2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/jmedgenet-2017-104877","volume":"55","author":"N Calmels","year":"2018","unstructured":"Calmels N, Botta E, Jia N, Fawcett H, Nardo T, Nakazawa Y, et al. Functional and clinical relevance of novel mutations in a large cohort of patients with Cockayne syndrome. J Med Genet. 2018;55:329\u201343.","journal-title":"J Med Genet"},{"key":"1910_CR3","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/j.neuroscience.2006.12.020","volume":"145","author":"KH Kraemer","year":"2007","unstructured":"Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, DiGiovanna JJ. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience. 2007;145:1388\u201396.","journal-title":"Neuroscience"},{"key":"1910_CR4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrm.2016.48","volume":"17","author":"R Ceccaldi","year":"2016","unstructured":"Ceccaldi R, Sarangi P, D\u2019Andrea AD. The Fanconi anaemia pathway: new players and new functions. Nat Rev Mol Cell Biol. 2016;17:337\u201349.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"1910_CR5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.gene.2015.06.026","volume":"569","author":"M Manandhar","year":"2015","unstructured":"Manandhar M, Boulware KS, Wood RD. The ERCC1 and ERCC4 (XPF) genes and gene products. Gene. 2015;569:153\u201361.","journal-title":"Gene"},{"key":"1910_CR6","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1093\/emboj\/19.20.5552","volume":"19","author":"GM Adair","year":"2000","unstructured":"Adair GM, Rolig RL, Moore-Faver D, Zabelshansky M, Wilson JH, Nairn RS. Role of ERCC1 in removal of long non-homologous tails during targeted homologous recombination. Embo J. 2000;19:5552\u201361.","journal-title":"Embo J"},{"key":"1910_CR7","doi-asserted-by":"crossref","first-page":"5082","DOI":"10.1128\/MCB.00293-08","volume":"28","author":"A Ahmad","year":"2008","unstructured":"Ahmad A, Robinson AR, Duensing A, van Drunen E, Beverloo HB, Weisberg DB, et al. ERCC1-XPF endonuclease facilitates DNA double-strand break repair. Mol Cell Biol. 2008;28:5082\u201392.","journal-title":"Mol Cell Biol"},{"key":"1910_CR8","doi-asserted-by":"crossref","first-page":"7835","DOI":"10.1074\/jbc.273.14.7835","volume":"273","author":"WL de Laat","year":"1998","unstructured":"de Laat WL, Appeldoorn E, Jaspers NG, Hoeijmakers JH. DNA structural elements required for ERCC1-XPF endonuclease activity. J Biol Chem. 1998;273:7835\u201342.","journal-title":"J Biol Chem"},{"key":"1910_CR9","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molcel.2014.03.015","volume":"54","author":"D Klein Douwel","year":"2014","unstructured":"Klein Douwel D, Boonen RA, Long DT, Szypowska AA, Raschle M, Walter JC, et al. XPF-ERCC1 acts in unhooking DNA interstrand crosslinks in cooperation with FANCD2 and FANCP\/SLX4. Mol Cell. 2014;54:460\u201371.","journal-title":"Mol Cell"},{"key":"1910_CR10","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1093\/nar\/26.18.4146","volume":"26","author":"WL de Laat","year":"1998","unstructured":"de Laat WL, Sijbers AM, Odijk H, Jaspers NG, Hoeijmakers JH. Mapping of interaction domains between human repair proteins ERCC1 and XPF. Nucleic Acids Res. 1998;26:4146\u201352.","journal-title":"Nucleic Acids Res"},{"key":"1910_CR11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0092-8674(00)80155-5","volume":"86","author":"AM Sijbers","year":"1996","unstructured":"Sijbers AM, de Laat WL, Ariza RR, Biggerstaff M, Wei YF, Moggs JG, et al. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell. 1996;86:811\u201322.","journal-title":"Cell"},{"key":"1910_CR12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1086\/512486","volume":"80","author":"NG Jaspers","year":"2007","unstructured":"Jaspers NG, Raams A, Silengo MC, Wijgers N, Niedernhofer LJ, Robinson AR, et al. First reported patient with human ERCC1 deficiency has cerebro-oculo-facio-skeletal syndrome with a mild defect in nucleotide excision repair and severe developmental failure. Am J Hum Genet. 2007;80:457\u201366.","journal-title":"Am J Hum Genet"},{"key":"1910_CR13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.ajhg.2013.04.007","volume":"92","author":"K Kashiyama","year":"2013","unstructured":"Kashiyama K, Nakazawa Y, Pilz DT, Guo C, Shimada M, Sasaki K, et al. Malfunction of nuclease ERCC1-XPF results in diverse clinical manifestations and causes Cockayne syndrome, xeroderma pigmentosum, and Fanconi anemia. Am J Hum Genet. 2013;92:807\u201319.","journal-title":"Am J Hum Genet"},{"key":"1910_CR14","first-page":"S92","volume":"127","author":"K Imoto","year":"2007","unstructured":"Imoto K, Boyle J, Oh K, Khan S, Ueda T, Nadem C, et al. Patients with defects in the interacting nucleotide excision repair proteins ERCC1 or XPF show xeroderma pigmentosum with late onset severe neurological degeneration. (Abstract). J Invest Derm. 2007;127:S92.","journal-title":"J Invest Derm"},{"key":"1910_CR15","doi-asserted-by":"crossref","unstructured":"Apelt K, White SM, Kim HS, Yeo JE, Kragten A, Wondergem AP, et al. ERCC1 mutations impede DNA damage repair and cause liver and kidney dysfunction in patients. J Exp Med. 2021;218:e20200622.","DOI":"10.1084\/jem.20200622"},{"key":"1910_CR16","volume":"120","author":"D van den Heuvel","year":"2023","unstructured":"van den Heuvel D, Kim M, Wondergem AP, van der Meer PJ, Witkamp M, Lambregtse F, et al. A disease-associated XPA allele interferes with TFIIH binding and primarily affects transcription-coupled nucleotide excision repair. Proc Natl Acad Sci USA. 2023;120:e2208860120.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1910_CR17","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.0504341102","volume":"102","author":"OV Tsodikov","year":"2005","unstructured":"Tsodikov OV, Enzlin JH, Scharer OD, Ellenberger T. Crystal structure and DNA binding functions of ERCC1, a subunit of the DNA structure-specific endonuclease XPF-ERCC1. Proc Natl Acad Sci USA. 2005;102:11236\u201341.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1910_CR18","doi-asserted-by":"crossref","first-page":"4768","DOI":"10.1038\/sj.emboj.7601894","volume":"26","author":"OV Tsodikov","year":"2007","unstructured":"Tsodikov OV, Ivanov D, Orelli B, Staresincic L, Shoshani I, Oberman R, et al. Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA. Embo J. 2007;26:4768\u201376.","journal-title":"Embo J"},{"key":"1910_CR19","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.1074\/jbc.M109.067538","volume":"285","author":"B Orelli","year":"2010","unstructured":"Orelli B, McClendon TB, Tsodikov OV, Ellenberger T, Niedernhofer LJ, Scharer OD. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways. J Biol Chem. 2010;285:3705\u201312.","journal-title":"J Biol Chem"},{"key":"1910_CR20","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/s41586-020-2308-7","volume":"581","author":"KJ Karczewski","year":"2020","unstructured":"Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alfoldi J, Wang Q, et al. The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020;581:434\u201343.","journal-title":"Nature"},{"key":"1910_CR21","doi-asserted-by":"crossref","unstructured":"van der Meer PJ, Van Den Heuvel D, Luijsterburg MS, Unscheduled DNA synthesis at sites of local UV-induced DNA damage to quantify global genome nucleotide excision repair activity in human cells. Bio Protoc. 2023;13:e4609.","DOI":"10.21769\/BioProtoc.4609"},{"key":"1910_CR22","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.dnarep.2010.01.015","volume":"9","author":"Y Nakazawa","year":"2010","unstructured":"Nakazawa Y, Yamashita S, Lehmann AR, Ogi T. A semi-automated non-radioactive system for measuring recovery of RNA synthesis and unscheduled DNA synthesis using ethynyluracil derivatives. DNA Repair. 2010;9:506\u201316.","journal-title":"DNA Repair"},{"key":"1910_CR23","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-biophys-051013-022737","volume":"43","author":"H Walden","year":"2014","unstructured":"Walden H, Deans AJ. The Fanconi anemia DNA repair pathway: structural and functional insights into a complex disorder. Annu Rev Biophys. 2014;43:257\u201378.","journal-title":"Annu Rev Biophys"},{"key":"1910_CR24","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/em.20569","volume":"51","author":"RD Wood","year":"2010","unstructured":"Wood RD. Mammalian nucleotide excision repair proteins and interstrand crosslink repair. Environ Mol Mutagen. 2010;51:520\u20136.","journal-title":"Environ Mol Mutagen"},{"key":"1910_CR25","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.15252\/embj.201796664","volume":"36","author":"UB Abdullah","year":"2017","unstructured":"Abdullah UB, McGouran JF, Brolih S, Ptchelkine D, El-Sagheer AH, Brown T, et al. RPA activates the XPF-ERCC1 endonuclease to initiate processing of DNA interstrand crosslinks. Embo J. 2017;36:2047\u201360.","journal-title":"Embo J"},{"key":"1910_CR26","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ajh.23153","volume":"87","author":"C Masserot-Lureau","year":"2012","unstructured":"Masserot-Lureau C, Adoui N, Degos F, de Bazelaire C, Soulier J, Chevret S, et al. Incidence of liver abnormalities in Fanconi anemia patients. Am J Hematol. 2012;87:547\u20139.","journal-title":"Am J Hematol"},{"key":"1910_CR27","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/mds.29071","volume":"37","author":"I Cordts","year":"2022","unstructured":"Cordts I, Onder D, Traschutz A, Kobeleva X, Karin I, Minnerop M, et al. Adult-onset neurodegeneration in nucleotide excision repair disorders (NERD(ND)): time to move beyond the skin. Mov Disord. 2022;37:1707\u201318.","journal-title":"Mov Disord"},{"key":"1910_CR28","volume":"11","author":"M Jones","year":"2020","unstructured":"Jones M, Beuron F, Borg A, Nans A, Earl CP, Briggs DC, et al. Cryo-EM structures of the XPF-ERCC1 endonuclease reveal how DNA-junction engagement disrupts an auto-inhibited conformation. Nat Commun. 2020;11:1120.","journal-title":"Nat Commun"},{"key":"1910_CR29","doi-asserted-by":"crossref","first-page":"e1008555","DOI":"10.1371\/journal.pgen.1008555","volume":"16","author":"L Mulderrig","year":"2020","unstructured":"Mulderrig L, Garaycoechea JI. XPF-ERCC1 protects liver, kidney and blood homeostasis outside the canonical excision repair pathways. PLoS Genet. 2020;16:e1008555.","journal-title":"PLoS Genet"},{"key":"1910_CR30","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0960-9822(06)00190-4","volume":"7","author":"G Weeda","year":"1997","unstructured":"Weeda G, Donker I, de Wit J, Morreau H, Janssens R, Vissers CJ, et al. Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence. Curr Biol. 1997;7:427\u201339.","journal-title":"Curr Biol"},{"key":"1910_CR31","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/ng1193-217","volume":"5","author":"J McWhir","year":"1993","unstructured":"McWhir J, Selfridge J, Harrison DJ, Squires S, Melton DW. Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Nat Genet. 1993;5:217\u201324.","journal-title":"Nat Genet"},{"key":"1910_CR32","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1128\/MCB.24.3.1200-1205.2004","volume":"24","author":"M Tian","year":"2004","unstructured":"Tian M, Shinkura R, Shinkura N, Alt FW. Growth retardation, early death, and DNA repair defects in mice deficient for the nucleotide excision repair enzyme XPF. Mol Cell Biol. 2004;24:1200\u20135.","journal-title":"Mol Cell Biol"},{"key":"1910_CR33","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/hep.24713","volume":"55","author":"SQ Gregg","year":"2012","unstructured":"Gregg SQ, Gutierrez V, Robinson AR, Woodell T, Nakao A, Ross MA, et al. A mouse model of accelerated liver aging caused by a defect in DNA repair. Hepatology. 2012;55:609\u201321.","journal-title":"Hepatology"},{"key":"1910_CR34","doi-asserted-by":"crossref","unstructured":"Dolle ME, Kuiper RV, Roodbergen M, Robinson J, de Vlugt S, Wijnhoven SW et al. Broad segmental progeroid changes in short-lived Ercc1(-\/Delta7) mice. Pathobiol Aging Age Relat Dis. 2011;1:7219.","DOI":"10.3402\/pba.v1i0.7219"},{"key":"1910_CR35","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1093\/nar\/29.22.4541","volume":"29","author":"J Selfridge","year":"2001","unstructured":"Selfridge J, Hsia KT, Redhead NJ, Melton DW. Correction of liver dysfunction in DNA repair-deficient mice with an ERCC1 transgene. Nucleic Acids Res. 2001;29:4541\u201350.","journal-title":"Nucleic Acids Res"},{"key":"1910_CR36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmg.2019.01.002","volume":"63","author":"A Stern-Delfils","year":"2020","unstructured":"Stern-Delfils A, Spitz MA, Durand M, Obringer C, Calmels N, Olagne J, et al. Renal disease in Cockayne syndrome. Eur J Med Genet. 2020;63:103612.","journal-title":"Eur J Med Genet"},{"key":"1910_CR37","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2164-14-559","volume":"14","author":"B Schermer","year":"2013","unstructured":"Schermer B, Bartels V, Frommolt P, Habermann B, Braun F, Schultze JL, et al. Transcriptional profiling reveals progeroid Ercc1(-\/Delta) mice as a model system for glomerular aging. BMC Genomics. 2013;14:559.","journal-title":"BMC Genomics"},{"key":"1910_CR38","volume":"704","author":"EY Hama","year":"2024","unstructured":"Hama EY, Nakamichi R, Hishikawa A, Kihara M, Abe T, Yoshimoto N, et al. Podocyte Ercc1 is indispensable for glomerular integrity. Biochem Biophys Res Commun. 2024;704:149713.","journal-title":"Biochem Biophys Res Commun"},{"key":"1910_CR39","doi-asserted-by":"crossref","unstructured":"Braun F, Mandel AM, Blomberg L, Wong MN, Chatzinikolaou G, Meyer DH, et al. Loss of genome maintenance is linked to mTORC1 signaling and accelerates podocyte damage. JCI Insight. 2025;10e172370.","DOI":"10.1172\/jci.insight.172370"},{"key":"1910_CR40","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.molcel.2015.08.020","volume":"60","author":"LB Pontel","year":"2015","unstructured":"Pontel LB, Rosado IV, Burgos-Barragan G, Garaycoechea JI, Yu R, Arends MJ, et al. Endogenous formaldehyde is a hematopoietic stem cell genotoxin and metabolic carcinogen. Mol Cell. 2015;60:177\u201388.","journal-title":"Mol Cell"},{"key":"1910_CR41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41586-021-04133-7","volume":"600","author":"L Mulderrig","year":"2021","unstructured":"Mulderrig L, Garaycoechea JI, Tuong ZK, Millington CL, Dingler FA, Ferdinand JR, et al. Aldehyde-driven transcriptional stress triggers an anorexic DNA damage response. Nature. 2021;600:158\u201363.","journal-title":"Nature"},{"key":"1910_CR42","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/nature05456","volume":"444","author":"LJ Niedernhofer","year":"2006","unstructured":"Niedernhofer LJ, Garinis GA, Raams A, Lalai AS, Robinson AR, Appeldoorn E, et al. A new progeroid syndrome reveals that genotoxic stress suppresses the somatotroph axis. Nature. 2006;444:1038\u201343.","journal-title":"Nature"},{"key":"1910_CR43","volume":"70","author":"AF O\u2019Neill","year":"2023","unstructured":"O\u2019Neill AF, Meyers RL, Katzenstein HM, Geller JI, Tiao GM, Lopez-Terrada D, et al. Children\u2019s Oncology Group\u2019s 2023 blueprint for research: liver tumors. Pediatr Blood Cancer. 2023;70:e172370.","journal-title":"Pediatr Blood Cancer"},{"key":"1910_CR44","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2147\/JHC.S94008","volume":"4","author":"I Schmid","year":"2017","unstructured":"Schmid I, von Schweinitz D. Pediatric hepatocellular carcinoma: challenges and solutions. J Hepatocell Carcinoma. 2017;4:15\u201321.","journal-title":"J Hepatocell Carcinoma"},{"key":"1910_CR45","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/pbc.23295","volume":"58","author":"I Schmid","year":"2012","unstructured":"Schmid I, Haberle B, Albert MH, Corbacioglu S, Frohlich B, Graf N, et al. Sorafenib and cisplatin\/doxorubicin (PLADO) in pediatric hepatocellular carcinoma. Pediatr Blood Cancer. 2012;58:539\u201344.","journal-title":"Pediatr Blood Cancer"}],"container-title":["European Journal of Human Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01910-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01910-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01910-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T09:25:37Z","timestamp":1759137937000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41431-025-01910-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,19]]},"references-count":45,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1038\/s41431-025-01910-0","relation":{},"ISSN":["1018-4813","1476-5438"],"issn-type":[{"value":"1018-4813","type":"print"},{"value":"1476-5438","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,19]]},"assertion":[{"value":"5 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This research project was conducted within the Rare Diseases Now project approved by the Royal Children\u2019s Hospital Ethics Committee, HREC approval 67401. Research protocols were approved via local institutional research boards and regional ethics committees, in keeping with national guidelines and the principles laid out in the Declaration of Helsinki. Verbal consent documented by the clinician was obtained from all patients or their parents\/guardians. Written consent was obtained and archived for all included patient photographs.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Declaration"}}]}}